Pharmaceutical composition for viral infections
AssigneeThe Administrators of the Tulane Educational Fund
InventorChad ROY
Life of this patent
Estimating the term…
Abstract
Disclosed herein are topical compositions comprising a quaternary ammonium salt and optionally ammonium chloride and/or stabilized chlorine dioxide. Also disclosed herein are methods of reducing the severity and/or duration of a dermal and or mucosal infection such as herpes or shingles. Also disclosed herein are methods of preventing the spread of a viral infection such as HIV. Also disclosed herein are methods of treating a viral infection such as keratoconjunctivitis.
Claims22
1-30. (canceled)
An anti-viral pharmaceutical composition comprising an active agent and a pharmaceutically acceptable carrier, wherein the active agent comprises C12-C14-alkyl(ethylbenzyl)dimethylammonium chloride.
The pharmaceutical composition of claim 1, wherein the pharmaceutical composition is in the form of an aerosol, a solution, a lotion, a gel, an ointment, a cream, a foam, a paste, or any combinations thereof.
A pharmaceutical composition comprising an active agent and a pharmaceutically acceptable carrier, wherein the active agent consists of C12-C14-alkyl(ethylbenzyl)dimethylammonium chloride.
Dependencies are inferred from the claim text.